Thomas Beetham - Sep 27, 2024 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Chief Operating Officer
Signature
/s/Thomas Beetham
Stock symbol
VRDN
Transactions as of
Sep 27, 2024
Transactions value $
$117,050
Form type
4
Date filed
9/30/2024, 07:12 PM
Previous filing
Nov 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRDN Common Stock Purchase $117K +5K +500% $23.41 6K Sep 27, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,000 shares acquired under Viridian Therapeutics, Inc.'s 2016 Employee Stock Purchase Plan (the "ESPP") on September 19, 2024 in transactions that were exempt under Rule 16b-3(c).

Remarks:

Exhibit 24 - Power of Attorney